Clinical Trials Directory

Trials / Unknown

UnknownNCT00309426

Effect of Fetuin A in Hemodialysis Patients

The Effect of Serum Fetuin A Concentration on the 5-Year Prognosis in Hemodialysis Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (planned)
Sponsor
University of Shizuoka · Academic / Other
Sex
All
Age
0 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examined the effect of fetuin A on atherosclerosis and prognosis in hemodialysis patients.

Detailed description

Fetuin A is known to be a potent inhibitor of ectopic calcification in plasma, and the concentration of fetuin A is closely associated with protein nutritional status. The purpose of this study is to examine whether the plasma concentration of fetuin A is associated with atherosclerosis and 5-year prognosis in hemodialysis patients.

Conditions

Timeline

Start date
2001-03-01
Completion
2006-03-01
First posted
2006-03-31
Last updated
2006-05-22

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT00309426. Inclusion in this directory is not an endorsement.